Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huiling Yang

Showing results (71-80 of 156) with videos related to

Pageof 16
Sort By:
BMC Cancer|June 11, 2010
Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinomaZhen Liu, Lixia Li, Zhixiong Yang, et al.
Biological & Pharmaceutical Bulletin|July 8, 2010
A new cyclooxygenase-2 inhibitor, (1E,4E)-1,5-bis(2-bromophenyl)penta-1,4-dien-3-one (GL63) suppresses cyclooxygenase-2 gene expression in human lung epithelial cancer cells: coupled mRNA stabilization and posttranscriptional inhibitionJian Xiao, Yi Tan, Yunbao Pan, et al.
Drug Design, Development and Therapy|February 23, 2023
The Underling Mechanisms Exploration of <i>Rubia cordifolia</i> L. Extract Against Rheumatoid Arthritis by Integrating Network Pharmacology and MetabolomicsWeiya Zeng, Yuan Fang, Suifen Mo, et al.
Antimicrobial Agents and Chemotherapy|June 3, 2010
Novel hepatitis C virus reporter replicon cell lines enable efficient antiviral screening against genotype 1aMargaret Robinson, Huiling Yang, Siu-Chi Sun, et al.
Antiviral Research|December 10, 2008
Development of a replicon-based phenotypic assay for assessing the drug susceptibilities of HCV NS3 protease genes from clinical isolatesXiaoping Qi, Andrew Bae, Shan Liu, et al.
Oncotarget|September 3, 2016
A directly negative interaction of miR-203 and ZEB2 modulates tumor stemness and chemotherapy resistance in nasopharyngeal carcinomaQingping Jiang, Ying Zhou, Huiling Yang, et al.
Integrative Cancer Therapies|December 4, 2025
Efficacy and Safety of Shenyi Capsule (Ginsenoside Rg3) as Adjuvant Therapy for Cancer: An Overview of Systematic Reviews and Meta-AnalysesCaixian Wu, Peicong Li, Huiling Yang, et al.
Histopathology|June 14, 2013
Loss of cytoplasmic KLF4 expression is correlated with the progression and poor prognosis of nasopharyngeal carcinomaZhen Liu, Huiling Yang, Weiren Luo, et al.
Journal of Virology|October 15, 2003
The hepatitis B virus polymerase mutation rtV173L is selected during lamivudine therapy and enhances viral replication in vitroWilliam E Delaney, Huiling Yang, Christopher E Westland, et al.
Cancer Cell International|October 16, 2020
MiR-1307-5p targeting TRAF3 upregulates the MAPK/NF-κB pathway and promotes lung adenocarcinoma proliferationXinyue Du, Shuangmiao Wang, Xingyan Liu, et al.
Pageof 16

Showing results (71-80 of 156) with videos related to

Sort By:
Pageof 16
BMC Cancer|June 11, 2010
Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinomaZhen Liu, Lixia Li, Zhixiong Yang, et al.
Biological & Pharmaceutical Bulletin|July 8, 2010
A new cyclooxygenase-2 inhibitor, (1E,4E)-1,5-bis(2-bromophenyl)penta-1,4-dien-3-one (GL63) suppresses cyclooxygenase-2 gene expression in human lung epithelial cancer cells: coupled mRNA stabilization and posttranscriptional inhibitionJian Xiao, Yi Tan, Yunbao Pan, et al.
Drug Design, Development and Therapy|February 23, 2023
The Underling Mechanisms Exploration of <i>Rubia cordifolia</i> L. Extract Against Rheumatoid Arthritis by Integrating Network Pharmacology and MetabolomicsWeiya Zeng, Yuan Fang, Suifen Mo, et al.
Antimicrobial Agents and Chemotherapy|June 3, 2010
Novel hepatitis C virus reporter replicon cell lines enable efficient antiviral screening against genotype 1aMargaret Robinson, Huiling Yang, Siu-Chi Sun, et al.
Antiviral Research|December 10, 2008
Development of a replicon-based phenotypic assay for assessing the drug susceptibilities of HCV NS3 protease genes from clinical isolatesXiaoping Qi, Andrew Bae, Shan Liu, et al.
Oncotarget|September 3, 2016
A directly negative interaction of miR-203 and ZEB2 modulates tumor stemness and chemotherapy resistance in nasopharyngeal carcinomaQingping Jiang, Ying Zhou, Huiling Yang, et al.
Integrative Cancer Therapies|December 4, 2025
Efficacy and Safety of Shenyi Capsule (Ginsenoside Rg3) as Adjuvant Therapy for Cancer: An Overview of Systematic Reviews and Meta-AnalysesCaixian Wu, Peicong Li, Huiling Yang, et al.
Histopathology|June 14, 2013
Loss of cytoplasmic KLF4 expression is correlated with the progression and poor prognosis of nasopharyngeal carcinomaZhen Liu, Huiling Yang, Weiren Luo, et al.
Journal of Virology|October 15, 2003
The hepatitis B virus polymerase mutation rtV173L is selected during lamivudine therapy and enhances viral replication in vitroWilliam E Delaney, Huiling Yang, Christopher E Westland, et al.
Cancer Cell International|October 16, 2020
MiR-1307-5p targeting TRAF3 upregulates the MAPK/NF-κB pathway and promotes lung adenocarcinoma proliferationXinyue Du, Shuangmiao Wang, Xingyan Liu, et al.
Pageof 16